A detailed history of Dimensional Fund Advisors LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 9,258,169 shares of ABBV stock, worth $1.63 Billion. This represents 0.45% of its overall portfolio holdings.

Number of Shares
9,258,169
Previous 8,841,189 4.72%
Holding current value
$1.63 Billion
Previous $1.52 Billion 20.57%
% of portfolio
0.45%
Previous 0.4%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $68.3 Million - $83.1 Million
416,980 Added 4.72%
9,258,169 $1.83 Billion
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $96.5 Million - $113 Million
623,569 Added 7.59%
8,841,189 $1.52 Billion
Q1 2024

May 10, 2024

BUY
$159.82 - $182.1 $31.9 Million - $36.3 Million
199,368 Added 2.49%
8,217,620 $1.5 Billion
Q4 2023

Feb 07, 2024

BUY
$137.6 - $154.97 $29.9 Million - $33.7 Million
217,306 Added 2.79%
8,018,252 $1.24 Billion
Q3 2023

Nov 09, 2023

BUY
$133.59 - $154.65 $9.09 Million - $10.5 Million
68,013 Added 0.88%
7,800,946 $1.16 Billion
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $20.9 Million - $26 Million
157,871 Added 2.08%
7,732,933 $1.04 Billion
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $17.6 Million - $20.3 Million
121,787 Added 1.63%
7,575,062 $1.21 Billion
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $988,224 - $1.19 Million
7,145 Added 0.1%
7,453,275 $1.21 Billion
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $28 Million - $32.1 Million
-208,711 Reduced 2.73%
7,446,130 $1 Billion
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $31.5 Million - $40 Million
228,778 Added 3.08%
7,654,841 $1.17 Billion
Q1 2022

May 13, 2022

BUY
$131.98 - $163.75 $8.85 Million - $11 Million
67,037 Added 0.91%
7,426,063 $1.2 Billion
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $4.09 Million - $5.17 Million
38,052 Added 0.52%
7,359,026 $996 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $1.98 Million - $2.25 Million
-18,605 Reduced 0.25%
7,320,974 $790 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $1.85 Million - $2.06 Million
17,557 Added 0.24%
7,339,579 $827 Million
Q1 2021

May 14, 2021

BUY
$102.3 - $112.62 $65.4 Million - $72 Million
639,017 Added 9.56%
7,322,022 $792 Million
Q4 2020

Feb 25, 2021

BUY
$80.49 - $108.67 $538 Million - $726 Million
6,683,005 New
6,683,005 $716 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.